Lemonade (NYSE: LMND) is a new player who's really adding zest to the insurance industry. Its AI-powered underwriting enables it to write new policies much more efficiently than its less-tech-savvy traditional competitors.And in addition to its agent-related costs being a fraction of others, its unique Synthetic Agents marketing approach is providing a very lucrative LTV/CAC of 3X (which is very good).In this 7investing exclusive livestream event, I shared a formal presentation that included ins...
May 28, 2025•42 min•Season 5Ep. 6
The digital advertising industry is, in many ways, a bellwether of the American economy. It's a direct look at how and where companies are acquiring new customers, as well as how things are going in the business world. PubMatic (Nasdaq: PUBM) is one of the digital advertising industry's earliest trailblazers. Founded in 2006, its mission has always been to provide a platform for PUB lishers to auto MATIC ally monetize their websites, podcasts, and streaming TV channels with programmatic ads. In ...
May 16, 2025•45 min•Season 5Ep. 5
Today's 7investing podcast is all about Rocket Lab! The space economy is hitting an inflection point. And that will be good news for its earliest investors. Eastern European conflicts, standoffs between China and Taiwan, and new commercial interests are creating a trillion-dollar industry in Earth’s orbit. And this is much more than just glorified media hype. An unprecedented number of applications is forcing the FCC to streamline its review process, as the number of active satellites is growing...
May 15, 2025•45 min•Season 5Ep. 4
Today's 7investing podcast is all about Rocket Lab! The space economy is hitting an inflection point. And that will be good news for its earliest investors. Eastern European conflicts, standoffs between China and Taiwan, and new commercial interests are creating a trillion-dollar industry in Earth’s orbit. And this is much more than just glorified media hype. An unprecedented number of applications is forcing the FCC to streamline its review process, as the number of active satellites is growing...
May 14, 2025•45 min•Season 5Ep. 4
Three Catalysts that Could Send Crocs' Stock Soaring Originally recorded: May 9, 2025Some great investment opportunities are sexy tech companies that are growing quickly and everyone is familiar with. But others can be boring shoe companies, who are growing slowly and yet are ridiculously profitable. Crocs (Nasdaq: CROX) is an example of the latter. Stuck between the uncertainties of a recession, slowing consumer spending, and a trade war, CROX is now selling for just 7x its trailing earnings. T...
May 09, 2025•16 min•Season 5Ep. 3
Palantir and Upstart: Soaring Growth but Falling Stock Prices Originally recorded: May 7, 2025 Palantir Technologies (Nasdaq: PLTR) and Upstart Holdings (Nasdaq: UPST) are two of the market's hottest stocks. Both are using AI to enhance their intelligent platforms and are seeing their top-line growth accelerate. Yet curiously, even after reporting excellent quarterly results, both stocks are selling off significantly. Are there hidden risks that investors are becoming more worried about? Or have...
May 07, 2025•32 min•Season 5Ep. 2
What the heck is going on at Wolfspeed?! Originally recorded: May 6, 2025 The WSJ published an article that WOLF is now the most shorted stock in the entire US market. The company's CFO then unexpectedly stepped down. And yet even after what appeared to be the worst-case scenario, recent negotiations have resulted in its stock price doubling within just the past two weeks. I dug into the filings and took a closer look at a Bloomberg terminal with a special situations guru that I called up earlie...
May 06, 2025•20 min•Season 5Ep. 2
We're bringing back the 7investing podcast! After remaining dormant for a few months, 7investing founder Simon Erickson introduces the new-and-improved show format. That will include: Deeper company-specific insights - including Wolfspeed's financial stability, AMD's leap into the datacenter, Palantir's stock-based compensation, and The Trade Desk's valuation (and that is all just this week!) New guests - including those looking at different sectors of the market such as REITs, crypto, banking, ...
May 06, 2025•9 min•Season 5Ep. 1
Options guru Jeff Fischer discusses with 7investing how options can be used as a complement to stocks to boost the returns of a long-term investment portfolio. When used responsibly, options can be a fantastic way to boost the overall returns of an investment portfolio. But options are also shorter-term in nature and they are more highly-exposed to risks and uncertainties. So how, exactly, should investors be using them responsibly? Jeff Fischer has three decades of investing experience. Between...
Mar 10, 2025•31 min•Season 5Ep. 1
Crocs is a very inexpensive stock right now, which could represent an excellent value investment opportunity. Crocs is a global shoe retailer whose comfortable and inexpensive footwear generates $4 billion in annual sales. Its core Crocs brand is growing 17% internationally and 8% direct-to-consumer. Q3 sales got a boost from "Mini-Crocs" being included in McDonald's $MCD Happy Meals and "Batman Crocs" being sold through a recent partnership with DC Comics (both of which are quite adorable). But...
Jan 22, 2025•9 min•Season 2025Ep. 122
Taiwan Semiconductor $TSM , the world's largest chipmaking foundry, today just issued the largest CapEx forecast of its company's history. Does this mean the chip industry is finally escaping from its cyclical lows, and is ready for a rebound in 2025? TSMC's 4Q 2024 results showcased a 38% year-over-year increase in revenue and a 57% increase in earnings. Those were good numbers. But there might be even better news on the horizon. Management just approved a 2025 capital budget of between $38 bil...
Jan 16, 2025•7 min•Season 2025Ep. 116
Innovation and regulation are quite often at odds. Technology relentlessly marches onward; yet it also needs to safely serve the common good. This is ever so true in banking. While banking may have traditionally been considered to be a rather conservative industry, its innovation curve has steepened significantly as physical banks have gone digital, digital banks have employed AI for lending, and managed accounts are embracing cryptocurrencies. Today's 7investing podcast features two banking exp...
Dec 05, 2024•48 min•Season 5Ep. 1
It's an exciting time to invest in the banking sector. Newly-elected President Donald Trump has promised to relax regulations on banks, which could boost lending volumes. The Federal Reserve has lowered interest rates twice during the past two months, which could make companies more eager to borrow. In response, several publicly-traded financial services companies including Upstart Holdings (Nasdaq: UPST), Affirm Holdings (Nasdaq: AFRM), and SoFi Technologies (Nasdaq: SOFI) have seen their share...
Nov 19, 2024•41 min•Season 4Ep. 12
Veeva Systems (NYSE: VEEV) is helping pharmaceutical companies create and sell new drugs more efficiently. It's cloud-based software platforms Veeva CRM and Veeva Vault have become industry-standards; deeply embedded with Big Pharma's largest companies. There's an upcoming catalyst next year, as Veeva's CRM platform will migrate from being hosted by Salesforce to its own infrastructure. That will unlock opportunities for it to develop new software products -- perhaps even beyond life sciences --...
Oct 28, 2024•10 min•Season 4Ep. 11
The Dutch lithography juggernaut ASML (Nasdaq: ASML) has been one of the semiconductor industry's best performing stocks of the past decade. Yet its high-flying shares have sold off 33% in the past three months, perhaps due to its underwhelming forward guidance that could indicate slowing demand. ASML has looked to Intel (Nasdaq: INTC) for much of its growth this past year. Intel has been all-in on expanding its foundry group and aggressively placed orders for six of ASML's latest-and-greatest E...
Oct 21, 2024•14 min•Season 4Ep. 10
Lululemon (Nasdaq: LULU) has expanded from being a niche yoga retailer to an international fitness super-brand. New CEO Calvin McDonald has tripled its sales in five years and maintained its industry-leading 20% operating margin. Yet recently, perhaps due to concerns of a slowdown in consumer spending or of rising competition, the stock has been selling for a dirt-cheap valuation. Now priced at just 15x its trailing cash flow, it could an inexpensive opportunity for opportunistic investors to co...
Oct 18, 2024•6 min•Season 4Ep. 9
Our newest stock recommendation is now live! On the 1st of each month, 7investing issues its newest official recommendation. This is the one stock it feels most confident in adding to its scorecard (which we also track in real-time at 7investing.com/recommendations ). What led us to recommend this Large Cap, Moderate Risk, Retail company this month? In today's episode, Simon describes 5 specific metrics that investors should consider when selecting stocks -- especially now that the Fed's cutting...
Oct 01, 2024•10 min•Season 4Ep. 6
Booking Holdings (Nasdaq: BKNG) is one of the most efficient publicly-traded companies in the world, converting 50% of its 2024 revenue into cold, hard cash flow. Furthermore, it's using those operating cash flows in shareholder-friendly ways, such as repurchase large amounts of its stock and a newly-initiated dividend. 7investing CEO Simon Erickson takes a look at the company's second quarter results and discuss several initiatives that could be even better news for investors going forward. To ...
Sep 26, 2024•6 min•Season 4Ep. 9
7investing's Watch List of New Ideas introduces stocks that we've never formally recommended yet are worth considering as future scorecard additions. You can think of this as our pipeline of new investment opportunities. This month, 7investing CEO Simon Erickson is adding two new two European companies: BE Semiconductor (OTC: BESIY) and Novo Nordisk (NYSE: NVO). He describes why Besi's advanced packaging leadership makes it a natural winner from innovative new chip designs, and why Novo Nordisk ...
Sep 25, 2024•13 min•Season 4Ep. 8
Fertility benefits company Progyny's (Nasdaq: PGNY) stock is selling off 33% in today's trading session after announced it's losing its largest customer who accounted for 13% of the previous year's revenue. This customer was unnamed, but it's most likely Amazon . Even though Progyny has historically had nearly 100% client retention and receives excellent net promoter scores, this could be a red flag for investors. 7investing CEO Simon Erickson shares his thoughts about the company's previous str...
Sep 19, 2024•8 min•Season 4Ep. 7
Upstart Holdings (Nasdaq: UPST) has been one of the investing world's most volatile stocks. Since peaking at $400 per share in late 2021, its stock has fallen more than 90% and sits at just $35 today. Many believe this roller coaster ride has followed the American macroeconomy. The Zero Interest Rate policy directly following COVID was replaced by the fastest rise in interest rates the United States had ever seen in 2022. Yet Upstart might be seeing signs of life. It issued optimistic revenue gu...
Sep 16, 2024•6 min•Season 4Ep. 6
Sometimes in investing, it's important to change your mind. Such is the case for Celsius Holdings (Nasdaq: CELH). This energy drink company represented one of our highest-conviction ideas in August. Yet further diligence revealed multiple red flags, which 7investing CEO Simon Erickson considers to be deal-breakers for long-term investors. In today's podcast episode, he describes several of those warnings signs and why he's turned from bullish to bearish about Celsius' future opportunity. Note: T...
Sep 12, 2024•14 min•Season 4Ep. 5
Wolfspeed (NYSE: WOLF) is one of Wall Street's ultimate battleground stocks. As the world's largest provider of silicon carbide, it supplies one of the most necessary materials for next-generation Electric Vehicles. Based on the size of its potential market and the long-term supply agreements with large automakers, its stock appears to be extremely undervalued. Yet Wolfspeed is also facing some serious headwinds, specifically in government-supported financing to construct its fabs and lagging de...
Sep 09, 2024•12 min•Season 4Ep. 4
Tesla always gives investors plenty to talk about! In today's show, 7investing CEO Simon Erickson describes 3 key takeaways from the company's second quarter report: - The all-time high in regulatory credits, driven by attractive financing rates and political uncertainty - The Energy business recognizing an all-time high in revenue and growing 100% in year-over-year comparisons - A production and deliveries update on the Model S, X, and Cybertruck. Overall, Simon believes Tesla's stock is only w...
Sep 06, 2024•12 min•Season 4Ep. 3
The "organ transplant as a service" market is taking the medical world by storm. How long can the accelerated growth rates continue? TransMedics (Nasdaq: TMDX) is a unique company you might have never heard of. But it’s playing an important role in saving the lives of thousands of Americans every year. As the creator of its patented Organ Care System (OCS), it is the only FDA-approved technology to transport lungs, hearts, and livers in the United States. When a registered donor is recently dece...
Sep 05, 2024•12 min•Season 4Ep. 2
United Therapeutics (Nasdaq: UTHR) is a very smart, very innovative, and very profitable company. First it treated an untreatable disease. Now it's disrupting the entire organ transplant industry. In today's show, 7investing CEO Simon Erickson introduces United Therapeutics, describing why the company was created and its five commercially-approved drugs. He also explains how its four synthetic organ programs could disrupt the entire organ transplant market. See why United Therapeutics is a stock...
Sep 04, 2024•11 min•Season 4Ep. 1
Innovative Industrial Properties is America's only publicly-traded REIT who's exclusively focused on the cannabis industries. It buys cannabis-growing facilities and then rents the spaces out to tenants through triple-net leases. Business was booming in the zero-interest rate economy, with IIP's committed capital skyrocketing 60-fold from $30 million in 2016 to $2 billion in 2023. But with interest rates rising and a shaky economy, growth is much slower these days. The stock currently pays a div...
Jun 05, 2024•6 min•Season 5Ep. 1
Tesla (Nasdaq: TSLA) is one of the market’s most unique battleground stocks. People either love it or they hate it, the financial media's commentary is either euphoric or miserable, and institutional price targets have ranged everywhere from $10 to $2,000. For the past two weeks, 7investing CEO Simon Erickson has been building a very detailed discounted cash flow for Tesla. He's put all emotions (and social interaction) aside and has let the numbers do the talking -- to develop his most-likely e...
May 21, 2024•22 min
If you’ve ever travelled abroad or tried to send money across international borders, hidden fees and unfair exchange rates have no doubt been a massive and expensive headache. In this week’s episode of the 7investing podcast, Lead Advisors Luke Hallard & Krzysztof Piekarski sit down with Rina Wulfing, Senior Manager for the North American policy team at Wise ($WIZEY) to discuss the company’s original founding story and mission: to empower its users with a transparent system that sends money ...
Apr 16, 2024•34 min
ShockWave Medical (Nasdaq: SWAV), the innovative pioneer of intravascular lithotripsy, has received an all-cash acquisition offer from Johnson & Johnson (NYSE: JNJ) for $335 per share. In today's episode, 7investing advisors Luke Hallard and Simon Erickson discuss why we made ShockWave a 7investing recommendation, several financial details of the offer, and what investors should expect going forward.
Apr 05, 2024•13 min
